Endocrinology, Vol 130, 282-288, Copyright © 1992 by Endocrine Society

ARTICLES

Physiological role of corticotropin-releasing factor in the control of adrenocorticotropin-mediated corticosterone release from the rat adrenal gland

JW van Oers, JP Hinson, R Binnekade and FJ Tilders
Department of Pharmacology, Medical Faculty, Free University, Amsterdam, The Netherlands.

Marked fluctuations in adrenal sensitivity to ACTH have been reported under both physiological (e.g. diurnal) and experimental conditions. Recently, we reported that immunoneutralization of CRF reduces resting corticosterone (cort) levels in rats without inducing concomitant reductions in plasma ACTH. We postulated an endogenous CRF mechanism that controls the adrenal sensitivity to ACTH. In the present study, this hypothesis was tested by iv infusion of human ACTH (0, 1, 3, and 10 ng/kg.min for 60 min) into dexamethasone-treated anaesthetized male Wistar rats. Serial blood samples were taken for the determination of ACTH and corticosterone by RIA (ACTHi, corti). Infusion of ACTH resulted in dose-dependent steady state plasma ACTHi levels, ranging from 50-600 pg/ml, which were not affected by prior administration of a rat monoclonal antibody to rat CRF (PFU 83). As expected, infusion of ACTH resulted in a dose-dependent increase in plasma corti. In PFU 83- treated rats, preinfusion plasma corti levels were reduced compared to those of rat immunoglobulin G-treated controls (7.8 +/- 1.2 vs 25.3 +/- 3.2 ng/ml). In addition, the corti responses to infusion of 1 and 3 ng/kg.min ACTH were suppressed by PFU 83. However, at a (near) maximally effective dose of ACTH (10 ng/kg.min), no differences in plasma corti were found between PFU 83 and immunoglobulin G-treated rats. These findings suggest that immunoneutralization of endogenous CRF results in a 3-fold reduction of the adrenal sensitivity to ACTH. Subsequently, we studied the possible effects of exogenous CRF on the isolated perfused adrenal gland in situ. In this preparation, CRF alone (1-100 pmol) or ACTH alone (5 fmol) did not affect the corti secretion rate or the flow rate of the perfusion medium through the gland. However, when given together a marked (up to 3.2 times) CRF dose- dependent stimulation of corti secretion and an increase (up to 1.7 times) in adrenal flow rate were obtained. In experiments with freshly dispersed adrenal cells in vitro, PFU 83 (1 microM) or CRF (0.1-10 nM) did not influence corti secretion when given alone and did not affect ACTH-induced corti secretion. It is unlikely, therefore, that CRF acts directly on the steroid-producing cells.(ABSTRACT TRUNCATED AT 400 WORDS)

This article has been cited by other articles:

				Y. Revsin, D. van Wijk, F. E. Saravia, M. S. Oitzl, A. F. De Nicola, and E. R. de Kloet Adrenal Hypersensitivity Precedes Chronic Hypercorticism in Streptozotocin-Induced Diabetes Mice Endocrinology, July 1, 2008; 149(7): 3531 - 3539. [Abstract] [Full Text] [PDF]

				M. O Huising, L. M van der Aa, J. R Metz, A. de Fatima Mazon, B M L. V.-v. Kemenade, and G. Flik Corticotropin-releasing factor (CRF) and CRF-binding protein expression in and release from the head kidney of common carp: evolutionary conservation of the adrenal CRF system J. Endocrinol., June 1, 2007; 193(3): 349 - 357. [Abstract] [Full Text] [PDF]

				D. X. Zhang, K. M. Gauthier, and W. B. Campbell Characterization of Vasoconstrictor Responses in Small Bovine Adrenal Cortical Arteries in Vitro Endocrinology, April 1, 2004; 145(4): 1571 - 1578. [Abstract] [Full Text] [PDF]

				L. J. M. J. Vanderschuren, E. D. Schmidt, T. J. De Vries, C. A. P. Van Moorsel, F. J.H. Tilders, and A. N. M. Schoffelmeer A Single Exposure to Amphetamine Is Sufficient to Induce Long-Term Behavioral, Neuroendocrine, and Neurochemical Sensitization in Rats J. Neurosci., November 1, 1999; 19(21): 9579 - 9586. [Abstract] [Full Text] [PDF]

				I. Dijkstra, F. J. H. Tilders, G. Aguilera, A. Kiss, C. Rabadan-Diehl, N. Barden, S. Karanth, F. Holsboer, and J. M. H. M. Reul Reduced Activity of Hypothalamic Corticotropin-Releasing Hormone Neurons in Transgenic Mice with Impaired Glucocorticoid Receptor Function J. Neurosci., May 15, 1998; 18(10): 3909 - 3918. [Abstract] [Full Text] [PDF]

				M. Ehrhart-Bornstein, J. P. Hinson, S. R. Bornstein, W. A. Scherbaum, and G. P. Vinson Intraadrenal Interactions in the Regulation of Adrenocortical Steroidogenesis Endocr. Rev., April 1, 1998; 19(2): 101 - 143. [Abstract] [Full Text]

				S. R. Bornstein, E. L. Webster, D. J. Torpy, S. J. Richman, N. Mitsiades, M. Igel, D. B. Lewis, K. C. Rice, H. G. Joost, M. Tsokos, et al. Chronic Effects of a Nonpeptide Corticotropin-Releasing Hormone Type I Receptor Antagonist on Pituitary-Adrenal Function, Body Weight, and Metabolic Regulation Endocrinology, April 1, 1998; 139(4): 1546 - 1555. [Abstract] [Full Text] [PDF]

				H. Nakamura, H. Nagase, M. Yoshida, K. Ogino, T. Seto, K. Hatta, and I. Matsuzaki Opioid peptides mediate heat stress-induced immunosuppression during pregnancy Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1998; 274(3): R672 - R676. [Abstract] [Full Text] [PDF]

				M. M. Sanchez, F. Aguado, F. Sanchez-Toscano, and D. Saphier Neuroendocrine and Immunocytochemical Demonstrations of Decreased Hypothalamo-Pituitary-Adrenal Axis Responsiveness to Restraint Stress after Long-Term Social Isolation Endocrinology, February 1, 1998; 139(2): 579 - 587. [Abstract] [Full Text] [PDF]

				M. J. P. Lenczowski, A.-M. Van Dam, S. Poole, J. W. Larrick, and F. J. H. Tilders Role of circulating endotoxin and interleukin-6 in the ACTH and corticosterone response to intraperitoneal LPS Am J Physiol Regulatory Integrative Comp Physiol, December 1, 1997; 273(6): R1870 - R1877. [Abstract] [Full Text] [PDF]

				R. F. McGivern, P. Rittenhouse, F. Aird, L. D. Van de Kar, and E. Redei Inhibition of Stress-Induced Neuroendocrine and Behavioral Responses in the Rat by Prepro-Thyrotropin-Releasing Hormone 178-199 J. Neurosci., June 15, 1997; 17(12): 4886 - 4894. [Abstract] [Full Text] [PDF]

				D. Sage, D. Maurel, and O. Bosler Corticosterone-dependent driving influence of the suprachiasmatic nucleus on adrenal sensitivity to ACTH Am J Physiol Endocrinol Metab, February 1, 2002; 282(2): E458 - E465. [Abstract] [Full Text] [PDF]